- Home
- CNTA vs INTR Comparison
CNTA vs INTR Comparison
Compare CNTA & INTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | INTR |
|---|---|---|
| Founded | 2020 | 1994 |
| Country | United Kingdom | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 3.4B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CNTA | INTR |
|---|---|---|
| Price | $39.58 | $7.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $43.17 | $10.00 |
| AVG Volume (30 Days) | 2.5M | ★ 3.0M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.51% |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | $84.07 |
| Revenue Next Year | N/A | $18.26 |
| P/E Ratio | ★ N/A | $16.39 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.95 | $6.40 |
| 52 Week High | $40.26 | $10.36 |
Technical Indicators
Market Signals| Indicator | CNTA | INTR |
|---|---|---|
| Relative Strength Index (RSI) | 73.62 | 37.38 |
| Support Level | $39.16 | $6.42 |
| Resistance Level | $40.26 | $8.73 |
| Average True Range (ATR) | 0.17 | 0.26 |
| MACD | -0.48 | -0.07 |
| Stochastic Oscillator | 76.27 | 11.32 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About INTR Inter & Co. Inc.
Inter & Co Inc operates as a digital bank. The company's segment includes Banking & Spending; Investments; Insurance Brokerage; and Inter Shop. It generates maximum revenue from the Banking & Spending segment which comprises a wide range of banking products and services, such as checking accounts, cards, deposits, loans and advances, and other services, which are available to the clients by means of Inter's mobile application.